The document presents a detailed analysis of the outcomes of Canadian health research grants, specifically by the Canadian Institutes of Health Research (CIHR), over the period from 2009 to 2024. Here are the key points summarized:
Key Findings:
-
Grant Overview:
- Analyzed 10,698 CIHR grants, categorized into commercialization-focused (COM), technology development (TECH), and basic science (SCI).
- COM grants showed much higher commercialization outputs, such as patent filings and company formations.
-
Efficiency of Grants:
- COM grants had a 60% patent success rate, compared to 30% for TECH and 18% for SCI.
- 10% of COM grants led to company formation.
-
Funding Disparities:
- CIHR’s total health research funding was ~CA$15 billion but significantly less than the US$580 billion for NIH in the U.S. over the same period.
- Suggests Canada needs to increase CIHR funding by a factor of five to compete globally.
-
Commercialization Gaps:
- Canada’s commercialization of academic research lags behind countries like the U.S., Germany, and the U.K.
- Structural issues, limited tech transfer office expertise, and varying institutional policies hinder commercialization.
-
Policy Recommendations:
- Expand CIHR’s commercialization-focused grant programs.
- Create a national IP framework similar to the Bayh-Dole Act in the U.S.
- Improve structural reforms to enhance the transition of research into commercial applications.
-
Comparison with U.S. Institutions:
- Analyzed CIHR grant outcomes vs. U.S. NIH funding at Emory University.
- CIHR researchers showed greater engagement in company-related activities despite lower average funding per recipient.
-
Longitudinal Nature of Research:
- Emphasizes the long timelines needed to transform scientific discoveries into marketable products.
-
Conclusion:
- The report calls for significant changes in funding models and policies to improve the commercialization potential of Canadian health research, which is recognized for its quality but constrained by insufficient investment and structural challenges.
Acknowledgments:
The research was funded by the Delaney Foundation, with editorial independence maintained by the authors.
Authors:
- Dr. Jeremy Hirota: Associate Professor at McMaster University and active innovator.
- Dr. Leonard Waverman: Professor of Finance and Business Economics at McMaster University.
- Jason Choi: Ph.D. candidate in Biochemistry at McMaster.
- Noah Kornberg: Designer and developer.
Centre for Canadian Innovation and Competitiveness:
An Ottawa-based organization aimed at improving public understanding of innovation economics and policies necessary for Canadian competitiveness.
This summary encapsulates the essence of the document while highlighting both the strengths and areas for improvement within the Canadian health research landscape.
